A detailed history of Prostatis Group LLC transactions in Danaher Corp stock. As of the latest transaction made, Prostatis Group LLC holds 40,664 shares of DHR stock, worth $11.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
40,664
Holding current value
$11.2 Million
% of portfolio
0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$224.99 - $256.14 $9.15 Million - $10.4 Million
40,664 New
40,664 $45.2 Million
Q4 2022

Mar 23, 2023

BUY
$241.42 - $282.29 $362,371 - $423,717
1,501 Added 2.78%
55,565 $60.6 Million
Q3 2022

Mar 23, 2023

BUY
$247.06 - $1507.4 $249,283 - $1.52 Million
1,009 Added 1.9%
54,064 $59 Million
Q2 2022

Mar 23, 2023

SELL
$237.11 - $299.66 $1.98 Million - $2.51 Million
-8,368 Reduced 13.62%
53,055 $57.4 Million
Q1 2022

Mar 23, 2023

SELL
$257.27 - $315.76 $1.96 Million - $2.4 Million
-7,604 Reduced 11.02%
61,423 $81.1 Million
Q4 2021

Mar 23, 2023

BUY
$292.08 - $329.01 $1.5 Million - $1.69 Million
5,146 Added 8.06%
69,027 $140 Million
Q3 2021

Mar 23, 2023

BUY
$272.21 - $332.43 $2.06 Million - $2.51 Million
7,553 Added 13.41%
63,881 $130 Million
Q2 2021

Mar 23, 2023

BUY
$225.08 - $271.69 $12.7 Million - $15.3 Million
56,328 New
56,328 $114 Million
Q4 2020

Mar 23, 2023

SELL
$212.5 - $245.46 $8.68 Million - $10 Million
-40,827 Closed
0 $0
Q3 2020

Mar 23, 2023

BUY
$177.16 - $215.33 $1.29 Million - $1.57 Million
7,296 Added 21.76%
40,827 $66 Million
Q2 2020

Mar 23, 2023

BUY
$128.7 - $176.83 $1.59 Million - $2.19 Million
12,385 Added 58.57%
33,531 $51.2 Million
Q1 2020

Mar 23, 2023

SELL
$121.39 - $169.05 $1.95 Million - $2.72 Million
-16,105 Reduced 43.23%
21,146 $35 Million
Q4 2019

Mar 23, 2023

BUY
$133.47 - $153.48 $4.97 Million - $5.72 Million
37,251 New
37,251 $52.6 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $200B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Prostatis Group LLC Portfolio

Follow Prostatis Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.